Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Total debt
Medtronic PLC's total debt at the end of fiscal 2026 was $28.0B, unchanged from fiscal 2025. At the end of the quarter to 31 July 2026 it was $28.2B. Over the past ten years it has ranged from $24.1B (fiscal 2022) to $36.2B (fiscal 2015); the current reading is higher than 67% of that period. Medtronic PLC ranks 2nd of 147 Medical Devices companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $28.0B | (1.95%) |
| FY2025 | $28.5B | 13.95% |
| FY2024 | $25.0B | 2.71% |
| FY2023 | $24.4B | 1.04% |
| FY2022 | $24.1B | (8.62%) |
| FY2021 | $26.4B | 6.42% |
| FY2020 | $24.8B | (2.08%) |
| FY2019 | $25.3B | (1.68%) |
| FY2018 | $25.8B | (22.98%) |
| FY2017 | $33.4B | 7.52% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jul 2026 | $28.2B | 0.69% |
| Apr 2026 | $28.0B | (0.39%) |
| Jan 2026 | $28.1B | (3.54%) |
| Oct 2025 | $29.1B | 1.72% |
| 43 more quarters | Free account |
Against its own ten years
Low $24.1B
High $36.2B
Ten-year median
$26.1B
Current reading's percentile
67
Total debt against peers
| Company | Total debt |
|---|---|
| ABT Abbott Laboratories compare | $32.6B |
| MDT Medtronic PLC | $28.2B |
| SYK Stryker Corporation compare | $14.9B |
| BSX Boston Scientific Corporation compare | $12.6B |
| GEHC GE HealthCare Technologies Inc. compare | $11.5B |
| PHG Koninklijke Philips N.V. compare | $7.3B |
| STE STERIS plc compare | $1.9B |
| DXCM DexCom, Inc. compare | $1.2B |
| EW Edwards Lifesciences Corporation compare | $598.7M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement